WallStreetZenWallStreetZen

NASDAQ: EOLS
Evolus Inc Stock

$12.51+0.06 (+0.48%)
Updated May 24, 2024
EOLS Price
$12.51
Fair Value Price
N/A
Market Cap
$783.26M
52 Week Low
$7.07
52 Week High
$15.43
P/E
-12.03x
P/B
42.47x
P/S
3.75x
PEG
N/A
Dividend Yield
N/A
Revenue
$219.70M
Earnings
-$60.00M
Gross Margin
69.3%
Operating Margin
-20.05%
Profit Margin
-27.3%
Debt to Equity
11.26
Operating Cash Flow
-$24M
Beta
1.13
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

EOLS Overview

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Zen Score

Industry Average (24)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how EOLS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

EOLS is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
EOLS is poor value based on its book value relative to its share price (42.47x), compared to the US Drug Manufacturers - Specialty & Generic industry average (2.16x)
P/B vs Industry Valuation
EOLS is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more EOLS due diligence checks available for Premium users.

Be the first to know about important EOLS news, forecast changes, insider trades & much more!

EOLS News

Valuation

EOLS fair value

Fair Value of EOLS stock based on Discounted Cash Flow (DCF)
Price
$12.51
Fair Value
$47.28
Undervalued by
73.54%
EOLS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

EOLS price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-12.03x
Industry
0.83x
Market
32.03x

EOLS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
42.47x
Industry
2.16x
EOLS is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

EOLS's financial health

Profit margin

Revenue
$59.3M
Net Income
-$13.1M
Profit Margin
-22.1%
EOLS's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
EOLS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$226.2M
Liabilities
$207.7M
Debt to equity
11.26
EOLS's short-term assets ($150.27M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
EOLS's long-term liabilities ($160.93M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
EOLS's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
EOLS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$10.6M
Investing
-$797.0k
Financing
$45.7M
EOLS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

EOLS vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
EOLS$783.26M+0.48%-12.03x42.47x
PAHC$751.34M+0.49%56.21x2.78x
CGC$836.43M+0.77%-0.57x2.06x
HROW$632.98M+2.23%-19.45x10.45x
IRWD$945.79M-1.82%-0.88x-2.86x

Evolus Stock FAQ

What is Evolus's quote symbol?

(NASDAQ: EOLS) Evolus trades on the NASDAQ under the ticker symbol EOLS. Evolus stock quotes can also be displayed as NASDAQ: EOLS.

If you're new to stock investing, here's how to buy Evolus stock.

What is the 52 week high and low for Evolus (NASDAQ: EOLS)?

(NASDAQ: EOLS) Evolus's 52-week high was $15.43, and its 52-week low was $7.07. It is currently -18.93% from its 52-week high and 76.94% from its 52-week low.

How much is Evolus stock worth today?

(NASDAQ: EOLS) Evolus currently has 62,610,487 outstanding shares. With Evolus stock trading at $12.51 per share, the total value of Evolus stock (market capitalization) is $783.26M.

Evolus stock was originally listed at a price of $11.50 in Feb 8, 2018. If you had invested in Evolus stock at $11.50, your return over the last 6 years would have been 8.78%, for an annualized return of 1.41% (not including any dividends or dividend reinvestments).

How much is Evolus's stock price per share?

(NASDAQ: EOLS) Evolus stock price per share is $12.51 today (as of May 24, 2024).

What is Evolus's Market Cap?

(NASDAQ: EOLS) Evolus's market cap is $783.26M, as of May 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Evolus's market cap is calculated by multiplying EOLS's current stock price of $12.51 by EOLS's total outstanding shares of 62,610,487.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.